The continuous glucose monitoring sensor in neonatal intensive care
- 1University of Cambridge, Department of Paediatrics, Addenbrooke’s Hospital, and Neonatal Unit, Rosie Maternity Hospital, Cambridge, UK
- 2Luton and Dunstable Hospital, Lewsey Road, Luton, UK
- Correspondence to:
Dr Beardsall
University of Cambridge, Department of Paediatrics, Addenbrooke’s Hospital, Hills Road, Cambridge CB2 2QQ, UK; kb274cam.ac.uk
- Accepted 19 January 2005
Abstract
Objective: To determine the feasibility of continuous glucose monitoring in the very low birthweight baby requiring intensive care, as these infants are known to be at high risk of abnormalities of glucose control.
Method: Sixteen babies were studied from within 24 hours of delivery and for up to seven days.
Results: The subcutaneous glucose sensors were well tolerated and readings were comparable to those on near patient whole blood monitoring devices.
Conclusion: Continuous glucose monitoring is practical in neonates, giving detailed information about glucose control.
Footnotes
-
Competing interests: Medtronic supplied the CGMS monitors
